| Drug Name: | Enprofylline (41078-02-8) |
|---|---|
| PubChem ID: | 1676 |
| SMILES: | CCCN1C2=C(C(=O)NC1=O)NC=N2 |
| InchiKey: | SIQPXVQCUCHWDI-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 194.194 |
| LogP | : | -0.1771 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 83.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Emesis | Acid sphinGOmyelinase-like phosphodiesterase (Q92484) | Emetic side effect of xanthine bronchodilators results from the inhibition of one or more forms of phosphodiesterase (PDE) [ ADR Type 1 ] | Mechanism for the emetic side effect of xanthine bronchodilators |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|